Position
Chief Financial Officer
Company
Transcenta Therapeutics
PrincetonBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Transcenta Therapeutics has announced the appointment of Jennie Ma as Chief Financial Officer. Ms. Ma brings over 20 years of extensive experience in financial management and will oversee the Company's financial management, capital markets activities, and corporate compliance.
Quick answer
Transcenta Therapeutics Appoints Jennie Ma as Chief Financial Officer (October 19, 2026). Transcenta Therapeutics is based in Princeton, New Jersey, United States.
- Who is the new Chief Financial Officer at Transcenta Therapeutics?
- Transcenta Therapeutics named Jennie Ma Chief Financial Officer, announced October 19, 2026.
- What did Transcenta Therapeutics announce on October 19, 2026?
- Transcenta Therapeutics has announced the appointment of Jennie Ma as Chief Financial Officer. Ms. Ma brings over 20 years of extensive experience in financial management and will oversee the Company's financial management, capital markets activities, and corporate compliance.
- What does Transcenta Therapeutics do?
- Transcenta Therapeutics is a global clinical-stage biopharmaceutical company specializing in the discovery and development of antibody-based therapeutics.
- Where is Transcenta Therapeutics based?
- Transcenta Therapeutics is based in Princeton, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Tempest Therapeutics (October 19, 2026), TORL BioTherapeutics (October 16, 2026), Gyre Therapeutics (October 22, 2026) and Retension Pharmaceuticals (October 23, 2026) also announced leadership changes within 45 days of Transcenta Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tempest Therapeutics Appoints John Frederick as Class III Director (October 19, 2026)
- TORL BioTherapeutics Appoints Sandip Kapadia as Chief Financial Officer and Eric Sievers, M.D. as Chief Medical Officer (October 16, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- Acadia Pharmaceuticals Announces Departure of Elizabeth H.Z. Thompson, Ph.D. (October 23, 2026)
- Verastem Oncology Appoints Michael P. Bailey as Chief Executive Officer (October 14, 2026)
Who to call at Transcenta Therapeutics, and when
A new leader at Transcenta Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Transcenta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Transcenta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Transcenta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Transcenta Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Transcenta Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.